Advanced radiotherapy for prostate cancer to cut sessions from 20 to five
NHS England is introducing stereotactic ablative radiotherapy (SABR) for prostate cancer patients, reducing the required treatment sessions from 20 to five. This high-precision technique aims to improve patient outcomes while minimizing side effects.
Why it matters
Advancements in radiotherapy significantly improve the quality of life for cancer patients and increase the efficiency of healthcare delivery systems.
Share Save Add as preferred on Google Nick Triggle Health correspondent Getty Images Thousands of men in England who have prostate cancer will be offered high-powered precision radiotherapy that will slash the number of treatment sessions they need from 20 to just five.
The report is a straightforward health news update based on clinical data and official NHS announcements.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in